ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase

被引:144
|
作者
Chi, Xun [1 ,2 ]
Britt, Emily C. [1 ,2 ]
Shows, Hannah W. [1 ,2 ]
Hjelmaas, Alexander J. [1 ,2 ]
Shetty, Shwetha K. [1 ,2 ]
Cushing, Emily M. [1 ,2 ]
Li, Wendy [1 ,2 ]
Dou, Alex [1 ,2 ]
Zhang, Ren [4 ]
Davies, Brandon S. J. [1 ,2 ,3 ]
机构
[1] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA
[2] Univ Iowa, Carver Coll Med, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA
[3] Univ Iowa, Carver Coll Med, Obes Res & Educ Initiat, Iowa City, IA 52242 USA
[4] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, 540 East Canfield St, Detroit, MI 48201 USA
来源
MOLECULAR METABOLISM | 2017年 / 6卷 / 10期
基金
美国国家卫生研究院;
关键词
Plasma triglycerides; Lipoprotein metabolism; Lipolysis; Lipase inhibition; TRIGLYCERIDE-RICH LIPOPROTEINS; ENDOTHELIAL-CELL TRANSPORTER; LIPID-METABOLISM; PROTEIN; MICE; IDENTIFICATION; BETATROPHIN; REPORTER; GPIHBP1; HORMONE;
D O I
10.1016/j.molmet.2017.06.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Several members of the angiopoietin-like (ANGPTL) family of proteins, including ANGPTL3 and ANGPTL8, regulate lipoprotein lipase (LPL) activity. Deficiency in either ANGPTL3 or ANGPTL8 reduces plasma triglyceride levels and increases LPL activity, whereas overexpression of either protein does the opposite. Recent studies suggest that ANGPTL8 may functionally interact with ANGPTL3 to alter clearance of plasma triglycerides; however, the nature of this interaction has remained elusive. We tested the hypothesis that ANGPTL8 forms a complex with ANGPTL3 and that this complex is necessary for the inhibition of vascular LPL by ANGPTL3. Methods: We analyzed the interactions of ANGPTL3 and ANGPTL8 with each other and with LPL using co-immunoprecipitation, western blotting, lipase activity assays, and the NanoBiT split-luciferase system. We also used adenovirus injection to overexpress ANGPTL3 in mice that lacked ANGPTL8. Results: We found that ANGPTL3 or ANGPTL8 alone could only inhibit LPL at concentrations that far exceeded physiological levels, especially when LPL was bound to its endothelial cell receptor/transporter GPIHBP1 (glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1). Physical interaction was observed between ANGPTL3 and ANGPTL8 when the proteins were co-expressed, and co-expression with ANGPTL3 greatly enhanced the secretion of ANGPTL8. Importantly, ANGPTL3 ANGPTL8 complexes had a dramatically increased ability to inhibit LPL compared to either protein alone. Adenovirus experiments showed that 2-fold overexpression of ANGPTL3 significantly increased plasma triglycerides only in the presence of ANGPTL8. Protein interaction assays showed that ANGPTL8 greatly increased the ability of ANGPTL3 to bind LPL. Conclusions: Together, these data indicate that ANGPTL8 binds to ANGPTL3 and that this complex is necessary for ANGPTL3 to efficiently bind and inhibit LPL. 2017 The Authors. Published by Elsevier GmbH. (C) 2017 The Authors. Published by Elsevier GmbH.
引用
收藏
页码:1137 / 1149
页数:13
相关论文
共 50 条
  • [41] Atypical angiopoietin-like protein that regulates ANGPTL3
    Quagliarini, Fabiana
    Wang, Yan
    Kozlitina, Julia
    Grishin, Nick V.
    Hyde, Rhonda
    Boerwinkle, Eric
    Valenzuela, David M.
    Murphy, Andrew J.
    Cohen, Jonathan C.
    Hobbs, Helen H.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (48) : 19751 - 19756
  • [42] Familial combined hypolipidemia due to mutations in the ANGPTL3 gene
    Calandra, Sebastiano
    Tarugi, Patrizia
    Averna, Maurizio
    Bertolini, Stefano
    CLINICAL LIPIDOLOGY, 2013, 8 (01) : 81 - 95
  • [43] Structures of Angptl3 and Angptl4, modulators of triglyceride levels and coronary artery disease
    Biterova, Ekaterina
    Esmaeeli, Mariam
    Alanen, Heli I.
    Saaranen, Mirva
    Ruddock, Lloyd W.
    SCIENTIFIC REPORTS, 2018, 8
  • [44] GALNT2 regulates ANGPTL3 cleavage in cells and in vivo of mice
    Li, Xuedan
    Zhang, Yiliang
    Zhang, Minzhu
    Wang, Yan
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [45] Circulating ANGPTL3 and ANGPTL4 levels predict coronary artery atherosclerosis severity
    Sun, Ting
    Zhan, Wanlin
    Wei, Lijiang
    Xu, Zuojun
    Fan, Li
    Zhuo, Yang
    Wang, Changqian
    Zhang, Junfeng
    LIPIDS IN HEALTH AND DISEASE, 2021, 20 (01)
  • [46] Decreased circulating levels of ANGPTL8 in Graves' disease patients
    Li, Haoxiang
    Xu, Mengjiao
    Zhao, Li
    Xia, Hong
    Li, Yanyan
    Hong, Xiafei
    Deng, Xia
    Yuan, Jing
    Ding, Yi
    Guo, Chang
    Pan, Ruirong
    Wang, Dong
    Wang, Jifang
    Yin, Wei
    Yang, Ling
    Yuan, Guoyue
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2019, 18 (02): : 189 - 195
  • [47] The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity
    Luo, Mengdie
    Zhang, Ziyu
    Peng, Yani
    Wang, Shuai
    Peng, Daoquan
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [48] ANGPTL3: a novel biomarker and promising therapeutic target
    Jiang, Shuang
    Qiu, Guo-Hui
    Zhu, Neng
    Hu, Zhe-Yu
    Liao, Duan-Fang
    Qin, Li
    JOURNAL OF DRUG TARGETING, 2019, 27 (08) : 876 - 884
  • [49] ANGPTL3 possibly promotes cardiac angiogenesis through improving proangiogenic ability of endothelial progenitor cells after myocardial infarction
    Luo, Fei
    Wu, Panyun
    Chen, Jingfei
    Guo, Yuan
    Wang, Jiangang
    Li, Xiangping
    Fang, Zhenfei
    LIPIDS IN HEALTH AND DISEASE, 2018, 17
  • [50] Emerging insights into the roles of ANGPTL8 beyond glucose and lipid metabolism
    Ye, Huimin
    Zong, Qunchuan
    Zou, Huajie
    Zhang, Ruixia
    FRONTIERS IN PHYSIOLOGY, 2023, 14